Successful IDH1mut models in our cohort were defined molecularly as high-grade astrocytomas with abundant chromosomal aberrations, CDKN2A/B loss, ATRX, and TP53 mutations and G-CIMP-low signature. This evidence concerns the gene ATRX and astrocytoma (excluding glioblastoma).